Retour

Dyadic to Attend Industry and Investor Events in May

Calendar Calendar of Events

JUPITER, Fla., May 08, 2024 (GLOBE NEWSWIRE) -- Dyadic International, Inc. (“Dyadic”, or the “Company”) (NASDAQ: DYAI), a global biotechnology company focused on building innovative microbial platforms to address the growing demand for global protein bioproduction and to develop and manufacture prophylactic, therapeutic, and nutritional biopharmaceutical products for human and animal health and wellness, today announced that its management will be attending the following industry and investor events during the month of May 2024.

GlobeNewswire Inc. • 08/05/2024 à 14:30:00
Dyadic International, Inc.
Address: 1044 NORTH U.S. HIGHWAY ONE
Postal Code: 33477
City: JUPITER
State: FL
Phone Number: 561-743-8333
Website: https://www.dyadic.com
Status: Active
Company Info

Dyadic International Inc is a world-wide biotechnology platform company. The company has developed a gene expression platform for producing commercial quantities of industrial enzymes and other proteins, and has licensed this technology to third parties, such as Abengoa Bioenergy, BASF, Codexis and others, for use in industrial (non-pharmaceutical) applications. This technology is based on the Thermothelomyces heterothallica fungus, which the company named C1.

List Date2004-11-05
MarketStocks
LocalUS
Primary ExchangeXNAS
TypeCS
Currency NameUSD
CIK0001213809
Composite figiBBG000L276R1
Share Class figiBBG001SJV0D6
Market Cap48,240,743 USD
SIC Code2836
SIC DescriptionBIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)
Total Employees7
Share Class Shares Outstanding29240000
Weighted Shares Outstanding29236814
Round Lot100
Updated date2024-05-19
Stats
Last 5 days
17-05
16-05
15-05
14-05
13-05
Last
1.641
1.68
1.565
1.485
1.52
Variance
-2.32%
7.35%
5.03%
-2.17%
5.56%
Open
1.68
1.565
1.49
1.518
1.44
Highest
2.1
1.725
1.67
1.52
1.54
Lowest
2.042
1.725
1.67
1.52
1.54
History
PeriodVarhighestlowest
1 week
13.96%
1.54
1.52
1 month
5.19%
1.569
1.47
3 month
15.08%
1.426
1.39
6 month
-5.84%
1.9
1.19
1 year
-20.72%
2.13
1.19
3 year
-53.25%
3.65
1.12
5 year
-60.17%
4.14
1.12
10 year
-56.24%
3.75
1.12
Stock Financials
Balance Sheet
LabelQuarter 1 (USD)Quarter 2 (USD)Quarter 3 (USD)Full Year (USD)
Filing date 2023-05-10 2023-08-09 2023-11-08 UNPUB
Assets 12,811,563 11,074,540 9,255,566 UNPUB
Current Assets 12,805,498 11,068,718 9,087,868 UNPUB
Current Liabilities 1,875,090 2,000,829 1,457,357 UNPUB
Equity 10,804,120 8,985,476 7,652,524 UNPUB
Equity Attributable To Noncontrolling Interest 0 0 0 UNPUB
Equity Attributable To Parent 10,804,120 8,985,476 7,652,524 UNPUB
Liabilities 2,007,443 2,089,064 1,603,042 UNPUB
Liabilities And Equity 12,811,563 11,074,540 9,255,566 UNPUB
Noncurrent Assets 6,065 5,822 167,698 UNPUB
Noncurrent Liabilities 132,353 88,235 145,685 UNPUB
Cash Flow Statement
LabelQuarter 1 (USD)Quarter 2 (USD)Quarter 3 (USD)Full Year (USD)
Filing date 2023-05-10 2023-08-09 2023-11-08 UNPUB
Exchange Gains/Losses UNPUB UNPUB UNPUB UNPUB
Net Cash Flow 0 0 0 UNPUB
Net Cash Flow, Continuing 0 0 0 UNPUB
Net Cash Flow From Financing Activities -580,302 533,598 -1,565,663 UNPUB
Net Cash Flow From Financing Activities, Continuing -580,302 533,598 -1,565,663 UNPUB
Net Cash Flow From Investing Activities 2,767,240 1,121,118 3,527,384 UNPUB
Net Cash Flow From Investing Activities, Continuing 2,767,240 1,121,118 3,527,384 UNPUB
Net Cash Flow From Operating Activities -2,186,938 -1,654,716 -1,961,721 UNPUB
Net Cash Flow From Operating Activities, Continuing -2,186,938 -1,654,716 -1,961,721 UNPUB
Comprehensive Income
LabelQuarter 1 (USD)Quarter 2 (USD)Quarter 3 (USD)Full Year (USD)
Filing date 2023-05-10 2023-08-09 2023-11-08 UNPUB
Comprehensive Income/Loss -956,444 -2,152,960 -1,614,259 UNPUB
Comprehensive Income/Loss Attributable To Noncontrolling Interest 0 0 0 UNPUB
Comprehensive Income/Loss Attributable To Parent -956,444 -2,152,960 -1,614,259 UNPUB
Other Comprehensive Income/Loss 0 0 0 UNPUB
Other Comprehensive Income/Loss Attributable To Parent UNPUB UNPUB UNPUB UNPUB
Income Statement
LabelQuarter 1 (USD)Quarter 2 (USD)Quarter 3 (USD)Full Year (USD)
Filing date 2023-05-10 2023-08-09 2023-11-08 UNPUB
Basic Earnings Per Share 0 0 0 UNPUB
Benefits Costs and Expenses 3,028,546 3,127,586 2,117,181 UNPUB
Cost Of Revenue 726,918 792,944 105,869 UNPUB
Costs And Expenses 3,028,546 3,127,586 2,117,181 UNPUB
Diluted Earnings Per Share UNPUB UNPUB UNPUB UNPUB
Gross Profit 251,134 44,215 291,191 UNPUB
Income/Loss From Continuing Operations After Tax -956,444 -2,152,960 -1,614,259 UNPUB
Income/Loss From Continuing Operations Before Tax -2,050,494 -2,290,427 -1,720,121 UNPUB
Income Tax Expense/Benefit UNPUB UNPUB UNPUB UNPUB
Interest Expense, Operating UNPUB UNPUB UNPUB UNPUB
Net Income/Loss -956,444 -2,152,960 -1,614,259 UNPUB
Net Income/Loss Attributable To Noncontrolling Interest 0 0 0 UNPUB
Net Income/Loss Attributable To Parent -956,444 -2,152,960 -1,614,259 UNPUB
Net Income/Loss Available To Common Stockholders, Basic -956,444 -2,152,960 -1,614,259 UNPUB
Operating Expenses 2,301,628 2,334,642 2,011,312 UNPUB
Operating Income/Loss -2,050,494 -2,290,427 -1,720,121 UNPUB
Participating Securities, Distributed And Undistributed Earnings/Loss, Basic 0 0 0 UNPUB
Preferred Stock Dividends And Other Adjustments 0 0 0 UNPUB
Revenues 978,052 837,159 397,060 UNPUB
Balance Sheet
LabelQuarter 1 (USD)Quarter 2 (USD)Quarter 3 (USD)Full Year (USD)
Filing date 2022-05-12 2022-08-10 2022-11-10 2023-03-29
Assets 18,530,241,000 17,223,497 15,219,162 13,712,818
Current Assets 16,241,308,000 16,932,764 14,928,450 13,422,064
Current Liabilities 1,826,480,000 3,397,348 2,386,644 2,448,608
Equity 16,394,938 13,561,443 12,611,930 11,087,739
Equity Attributable To Noncontrolling Interest 0 0 0 0
Equity Attributable To Parent 16,394,938 13,561,443 12,611,930 11,087,739
Liabilities 2,135,303,000 3,662,054 2,607,232 2,625,079
Liabilities And Equity 18,530,241,000 17,223,497 15,219,162 13,712,818
Noncurrent Assets 2,288,933,000 290,733 290,712 290,754
Noncurrent Liabilities 0 0 220,588 176,471
Cash Flow Statement
LabelQuarter 1 (USD)Quarter 2 (USD)Quarter 3 (USD)Full Year (USD)
Filing date 2022-05-12 2022-08-10 2022-11-10 2023-03-29
Exchange Gains/Losses UNPUB UNPUB UNPUB UNPUB
Net Cash Flow -3,328,883,000 3,322,622,280 -2,726,400 -9,909,464
Net Cash Flow, Continuing -3,328,883,000 3,322,622,280 -2,726,400 -9,909,464
Net Cash Flow From Financing Activities 42,350,000 -42,307,650 359,741 543,591
Net Cash Flow From Financing Activities, Continuing 42,350,000 -42,307,650 359,741 543,591
Net Cash Flow From Investing Activities -520,850,000 519,172,730 -1,309,928 -2,369,280
Net Cash Flow From Investing Activities, Continuing -520,850,000 519,172,730 -1,309,928 -2,369,280
Net Cash Flow From Operating Activities -2,850,383,000 2,845,757,200 -1,776,213 -8,083,775
Net Cash Flow From Operating Activities, Continuing -2,850,383,000 2,845,757,200 -1,776,213 -8,083,775
Comprehensive Income
LabelQuarter 1 (USD)Quarter 2 (USD)Quarter 3 (USD)Full Year (USD)
Filing date 2022-05-12 2022-08-10 2022-11-10 2023-03-29
Comprehensive Income/Loss -2,491,665 -3,287,995 -1,809,173 -9,735,258
Comprehensive Income/Loss Attributable To Noncontrolling Interest 0 0 0 0
Comprehensive Income/Loss Attributable To Parent -2,491,665 -3,287,995 -1,809,173 -9,735,258
Other Comprehensive Income/Loss 0 0 0 0
Other Comprehensive Income/Loss Attributable To Parent UNPUB UNPUB UNPUB UNPUB
Income Statement
LabelQuarter 1 (USD)Quarter 2 (USD)Quarter 3 (USD)Full Year (USD)
Filing date 2022-05-12 2022-08-10 2022-11-10 2023-03-29
Basic Earnings Per Share 0 0 0 0
Benefits Costs and Expenses 3,393,060,000 3,976,557 2,743,070 13,095,981
Cost Of Revenue 404,746,000 411,109 602,847 2,123,193
Costs And Expenses 3,393,060,000 3,976,557 2,743,070 13,095,981
Diluted Earnings Per Share UNPUB UNPUB UNPUB UNPUB
Gross Profit 243,681,000 247,444 276,750 807,110
Income/Loss From Continuing Operations After Tax -2,491,665 -3,287,995 -1,809,173 -9,735,258
Income/Loss From Continuing Operations Before Tax -2,491,665 -3,287,995 -1,863,473 -10,165,678
Income Tax Expense/Benefit UNPUB UNPUB UNPUB UNPUB
Interest Expense, Operating UNPUB UNPUB UNPUB UNPUB
Net Income/Loss -2,491,665 -3,287,995 -1,809,173 -9,735,258
Net Income/Loss Attributable To Noncontrolling Interest 0 0 0 0
Net Income/Loss Attributable To Parent -2,491,665 -3,287,995 -1,809,173 -9,735,258
Net Income/Loss Available To Common Stockholders, Basic -2,491,665 -3,287,995 -1,809,173 -9,735,258
Operating Expenses 2,988,314,000 3,565,448 2,140,223 10,972,788
Operating Income/Loss -2,744,633,000 -3,318,004 -1,863,473 -10,165,678
Participating Securities, Distributed And Undistributed Earnings/Loss, Basic 0 0 0 0
Preferred Stock Dividends And Other Adjustments 0 0 0 0
Revenues 648,427,000 658,553 879,597 2,930,303
Balance Sheet
LabelQuarter 1 (USD)Quarter 2 (USD)Quarter 3 (USD)Full Year (USD)
Filing date 2021-05-13 2021-08-12 2021-11-10 2022-03-29
Assets 28,282,212 26,447,254 23,863,052 21,299,122
Current Assets 27,991,352 26,156,373 23,572,200 21,008,296
Current Liabilities 2,593,729 3,288,485 1,962,932 2,555,719
Equity 25,688,483 23,158,769 21,900,120 18,390,462
Equity Attributable To Noncontrolling Interest 0 0 0 0
Equity Attributable To Parent 25,688,483 23,158,769 21,900,120 18,390,462
Liabilities -25,688,483 -23,158,769 1,962,932 2,908,660
Liabilities And Equity 28,282,212 26,447,254 23,863,052 21,299,122
Noncurrent Assets 290,860 290,881 290,852 290,826
Noncurrent Liabilities 0 0 0 352,941
Cash Flow Statement
LabelQuarter 1 (USD)Quarter 2 (USD)Quarter 3 (USD)Full Year (USD)
Filing date 2021-05-13 2021-08-12 2021-11-10 2022-03-29
Exchange Gains/Losses UNPUB UNPUB UNPUB UNPUB
Net Cash Flow -7,574,653 969,070 -329,156 -4,825,303
Net Cash Flow, Continuing -7,574,653 969,070 -329,156 -4,825,303
Net Cash Flow From Financing Activities 115,800 870,340 -590 1,230,050
Net Cash Flow From Financing Activities, Continuing 115,800 870,340 -590 1,230,050
Net Cash Flow From Investing Activities -5,783,940 2,500,000 4,005,532 5,221,592
Net Cash Flow From Investing Activities, Continuing -5,783,940 2,500,000 4,005,532 5,221,592
Net Cash Flow From Operating Activities -1,906,513 -2,401,270 -4,334,098 -11,276,945
Net Cash Flow From Operating Activities, Continuing -1,906,513 -2,401,270 -4,334,098 -11,276,945
Comprehensive Income
LabelQuarter 1 (USD)Quarter 2 (USD)Quarter 3 (USD)Full Year (USD)
Filing date 2021-05-13 2021-08-12 2021-11-10 2022-03-29
Comprehensive Income/Loss -3,294,949 -3,846,174 -1,715,268 -13,070,251
Comprehensive Income/Loss Attributable To Noncontrolling Interest 0 0 0 0
Comprehensive Income/Loss Attributable To Parent -3,294,949 -3,846,174 -1,715,268 -13,070,251
Other Comprehensive Income/Loss 0 0 0 0
Other Comprehensive Income/Loss Attributable To Parent UNPUB UNPUB UNPUB UNPUB
Income Statement
LabelQuarter 1 (USD)Quarter 2 (USD)Quarter 3 (USD)Full Year (USD)
Filing date 2021-05-13 2021-08-12 2021-11-10 2022-03-29
Basic Earnings Per Share UNPUB UNPUB UNPUB UNPUB
Benefits Costs and Expenses 3,781,139 4,804,166 4,016,931 17,131,318
Cost Of Revenue 390,762 829,504 392,544 1,944,438
Costs And Expenses 3,781,139 4,804,166 4,016,931 17,131,318
Diluted Earnings Per Share UNPUB UNPUB UNPUB UNPUB
Gross Profit 69,758 107,588 300,385 459,393
Income/Loss From Continuing Operations After Tax -3,294,949 -3,846,174 -1,715,268 -13,070,251
Income/Loss From Continuing Operations Before Tax -3,294,949 -3,846,174 -3,324,002 -14,727,487
Income Tax Expense/Benefit UNPUB UNPUB UNPUB 0
Interest Expense, Operating UNPUB UNPUB UNPUB UNPUB
Net Income/Loss -3,294,949 -3,846,174 -1,715,268 -13,070,251
Net Income/Loss Attributable To Noncontrolling Interest 0 0 0 0
Net Income/Loss Attributable To Parent -3,294,949 -3,846,174 -1,715,268 -13,070,251
Net Income/Loss Available To Common Stockholders, Basic -3,294,949 -3,846,174 -1,715,268 -13,070,251
Operating Expenses 3,390,377 3,974,662 3,624,387 15,186,880
Operating Income/Loss -3,320,619 -3,867,074 -3,324,002 -14,727,487
Participating Securities, Distributed And Undistributed Earnings/Loss, Basic 0 0 0 0
Preferred Stock Dividends And Other Adjustments 0 0 0 0
Revenues 460,520 937,092 692,929 2,403,831
Balance Sheet
LabelQuarter 1 (USD)Quarter 2 (USD)Quarter 3 (USD)Full Year (USD)
Filing date 2020-05-14 2020-08-13 2020-11-12 2021-03-30
Assets 35,388,090 33,731,621 31,745,704 30,072,432
Current Assets 32,819,441 33,725,505 31,740,146 29,781,498
Current Liabilities 1,135,819 1,638,416 1,751,250 1,625,871
Equity 34,252,271 32,093,205 29,994,454 28,446,561
Equity Attributable To Noncontrolling Interest 0 0 0 0
Equity Attributable To Parent 34,252,271 32,093,205 29,994,454 28,446,561
Liabilities -34,252,271 -32,093,205 1,751,250 1,625,871
Liabilities And Equity 35,388,090 33,731,621 31,745,704 30,072,432
Noncurrent Assets 2,568,649 6,116 5,558 290,934
Noncurrent Liabilities 0 0 0 0
Cash Flow Statement
LabelQuarter 1 (USD)Quarter 2 (USD)Quarter 3 (USD)Full Year (USD)
Filing date 2020-05-14 2020-08-13 2020-11-12 2021-03-30
Exchange Gains/Losses -2,983 6,330 8,444 10,370
Net Cash Flow -126,713 7,084,718 10,081,032 15,813,501
Net Cash Flow, Continuing -123,730 7,078,388 10,072,588 15,803,131
Net Cash Flow From Financing Activities 175,000 55,743 67 255,470
Net Cash Flow From Financing Activities, Continuing 175,000 55,743 67 255,470
Net Cash Flow From Investing Activities 1,697,615 8,930,229 11,456,000 22,122,053
Net Cash Flow From Investing Activities, Continuing 1,697,615 8,930,229 11,456,000 22,122,053
Net Cash Flow From Operating Activities -1,996,345 -1,907,584 -1,383,479 -6,574,392
Net Cash Flow From Operating Activities, Continuing -1,996,345 -1,907,584 -1,383,479 -6,574,392
Comprehensive Income
LabelQuarter 1 (USD)Quarter 2 (USD)Quarter 3 (USD)Full Year (USD)
Filing date 2020-05-14 2020-08-13 2020-11-12 2021-03-30
Comprehensive Income/Loss -2,214,139 -2,651,422 -2,499,499 -9,325,273
Comprehensive Income/Loss Attributable To Noncontrolling Interest 0 0 0 0
Comprehensive Income/Loss Attributable To Parent -2,214,139 -2,651,422 -2,499,499 -9,325,273
Other Comprehensive Income/Loss 0 0 0 0
Other Comprehensive Income/Loss Attributable To Parent UNPUB UNPUB UNPUB UNPUB
Income Statement
LabelQuarter 1 (USD)Quarter 2 (USD)Quarter 3 (USD)Full Year (USD)
Filing date 2020-05-14 2020-08-13 2020-11-12 2021-03-30
Basic Earnings Per Share UNPUB UNPUB UNPUB UNPUB
Benefits Costs and Expenses 2,697,894 3,322,280 2,992,669 11,627,584
Cost Of Revenue 278,182 624,240 266,929 1,424,931
Costs And Expenses 2,697,894 3,322,280 2,992,669 11,627,584
Diluted Earnings Per Share UNPUB UNPUB UNPUB UNPUB
Gross Profit 37,190 -99,969 149,432 176,990
Income/Loss From Continuing Operations After Tax -2,214,139 -2,651,422 -2,499,499 -9,325,273
Income/Loss From Continuing Operations Before Tax -2,214,139 -2,651,422 -2,576,308 -10,025,663
Income Tax Expense/Benefit 0 0 0 31,318
Interest Expense, Operating UNPUB UNPUB UNPUB UNPUB
Net Income/Loss -2,214,139 -2,651,422 -2,499,499 -9,325,273
Net Income/Loss Attributable To Noncontrolling Interest 0 0 0 0
Net Income/Loss Attributable To Parent -2,214,139 -2,651,422 -2,499,499 -9,325,273
Net Income/Loss Available To Common Stockholders, Basic -2,214,139 -2,651,422 -2,499,499 -9,325,273
Operating Expenses 2,419,712 2,698,040 2,725,740 10,202,653
Operating Income/Loss -2,382,522 -2,798,009 -2,576,308 -10,025,663
Participating Securities, Distributed And Undistributed Earnings/Loss, Basic 0 0 0 0
Preferred Stock Dividends And Other Adjustments 0 0 0 0
Revenues 315,372 524,271 416,361 1,601,921
Balance Sheet
LabelQuarter 1 (USD)Quarter 2 (USD)Quarter 3 (USD)Full Year (USD)
Filing date UNPUB 2019-08-13 2019-11-13 2020-03-30
Assets UNPUB 40,069,342 38,521,459 37,452,496
Current Assets UNPUB 38,000,481 36,456,458 35,639,238
Current Liabilities UNPUB 1,449,877 1,276,788 1,588,025
Equity UNPUB 38,619,465 37,244,671 35,864,471
Equity Attributable To Noncontrolling Interest UNPUB 0 0 0
Equity Attributable To Parent UNPUB 38,619,465 37,244,671 35,864,471
Liabilities UNPUB -38,619,465 1,276,788 1,588,025
Liabilities And Equity UNPUB 40,069,342 38,521,459 37,452,496
Noncurrent Assets UNPUB 2,068,861 2,065,001 1,813,258
Noncurrent Liabilities UNPUB 0 0 0
Cash Flow Statement
LabelQuarter 1 (USD)Quarter 2 (USD)Quarter 3 (USD)Full Year (USD)
Filing date UNPUB 2019-08-13 2019-11-13 2020-03-30
Exchange Gains/Losses UNPUB -10,669 -20,229 -37,516
Net Cash Flow UNPUB 2,388,029 -119,193 2,437,230
Net Cash Flow, Continuing UNPUB 2,398,698 -98,964 2,474,746
Net Cash Flow From Financing Activities UNPUB 1,738,627 179,410 550,188
Net Cash Flow From Financing Activities, Continuing UNPUB 1,745,804 179,410 550,188
Net Cash Flow From Investing Activities UNPUB 2,098,692 1,262,615 7,707,450
Net Cash Flow From Investing Activities, Continuing UNPUB 2,098,692 1,262,615 7,707,450
Net Cash Flow From Operating Activities UNPUB -1,431,444 -1,540,989 -5,782,892
Net Cash Flow From Operating Activities, Continuing UNPUB -1,431,444 -1,540,989 -5,782,892
Comprehensive Income
LabelQuarter 1 (USD)Quarter 2 (USD)Quarter 3 (USD)Full Year (USD)
Filing date UNPUB 2019-08-13 2019-11-13 2020-03-30
Comprehensive Income/Loss UNPUB -2,695,792 -1,698,384 -8,307,965
Comprehensive Income/Loss Attributable To Noncontrolling Interest UNPUB 0 0 0
Comprehensive Income/Loss Attributable To Parent UNPUB -2,695,792 -1,698,384 -8,307,965
Other Comprehensive Income/Loss UNPUB 0 0 0
Other Comprehensive Income/Loss Attributable To Parent UNPUB UNPUB UNPUB UNPUB
Income Statement
LabelQuarter 1 (USD)Quarter 2 (USD)Quarter 3 (USD)Full Year (USD)
Filing date UNPUB 2019-08-13 2019-11-13 2020-03-30
Basic Earnings Per Share UNPUB UNPUB UNPUB UNPUB
Benefits Costs and Expenses UNPUB 3,352,388 2,397,918 10,963,665
Cost Of Revenue UNPUB 322,228 384,803 1,459,701
Costs And Expenses UNPUB 3,352,388 2,397,918 10,963,665
Diluted Earnings Per Share UNPUB UNPUB UNPUB UNPUB
Gross Profit UNPUB 68,646 69,704 221,375
Income/Loss From Continuing Operations After Tax UNPUB -2,695,792 -1,698,384 -8,307,965
Income/Loss From Continuing Operations Before Tax UNPUB -2,695,792 -1,943,411 -9,282,589
Income Tax Expense/Benefit UNPUB 0 0 10,306
Interest Expense, Operating UNPUB UNPUB UNPUB UNPUB
Net Income/Loss UNPUB -2,695,792 -1,698,384 -8,307,965
Net Income/Loss Attributable To Noncontrolling Interest UNPUB 0 0 0
Net Income/Loss Attributable To Parent UNPUB -2,695,792 -1,698,384 -8,307,965
Net Income/Loss Available To Common Stockholders, Basic UNPUB -2,695,792 -1,698,384 -8,307,965
Operating Expenses UNPUB 3,030,160 2,013,115 9,503,964
Operating Income/Loss UNPUB -2,961,514 -1,943,411 -9,282,589
Participating Securities, Distributed And Undistributed Earnings/Loss, Basic UNPUB 0 0 0
Preferred Stock Dividends And Other Adjustments UNPUB 0 0 0
Revenues UNPUB 390,874 454,507 1,681,076
Calendar
19 May 2024 (Time UTC) Actual Previous Consensus
★★★
15:30
United States
17 May 2024 (Time UTC) Actual Previous Consensus
★
15:30
United States
-17800.000
★
15:30
United States
-60000.000
★
15:30
United States
53700.000
★
15:30
United States
-135800.000
★★
15:30
United States
4400.000
★
15:30
United States
215400.000
★
15:30
United States
-31400.000
★
15:30
United States
62600.000
★
15:30
United States
1300.000
★
15:30
United States
-9700.000
★
15:30
United States
199600.000
★★
15:30
United States
★
15:30
United States
★
15:30
United States
Options
Ticker
CFI
Contract Type
Exercise Style
Share Per Contract
Strike Price
Primary Exchange
Expiration Date
O:DYAI240517P00007500 OPASPS Put American 100 7.5 BATO 2024-05-17
O:DYAI240517P00005000 OPASPS Put American 100 5 BATO 2024-05-17
O:DYAI240517P00002500 OPASPS Put American 100 2.5 BATO 2024-05-17
O:DYAI240517C00007500 OCASPS Call American 100 7.5 BATO 2024-05-17
O:DYAI240517C00005000 OCASPS Call American 100 5 BATO 2024-05-17
O:DYAI240517C00002500 OCASPS Call American 100 2.5 BATO 2024-05-17
O:DYAI240419P00007500 OPASPS Put American 100 7.5 BATO 2024-04-19
O:DYAI240419P00005000 OPASPS Put American 100 5 BATO 2024-04-19
O:DYAI240419P00002500 OPASPS Put American 100 2.5 BATO 2024-04-19
O:DYAI240419C00007500 OCASPS Call American 100 7.5 BATO 2024-04-19
O:DYAI240419C00005000 OCASPS Call American 100 5 BATO 2024-04-19
O:DYAI240419C00002500 OCASPS Call American 100 2.5 BATO 2024-04-19
O:DYAI240315P00007500 OPASPS Put American 100 7.5 BATO 2024-03-15
O:DYAI240315P00005000 OPASPS Put American 100 5 BATO 2024-03-15
O:DYAI240315P00002500 OPASPS Put American 100 2.5 BATO 2024-03-15
O:DYAI240315C00007500 OCASPS Call American 100 7.5 BATO 2024-03-15
O:DYAI240315C00005000 OCASPS Call American 100 5 BATO 2024-03-15
O:DYAI240315C00002500 OCASPS Call American 100 2.5 BATO 2024-03-15
O:DYAI240216P00007500 OPASPS Put American 100 7.5 BATO 2024-02-16
O:DYAI240216P00005000 OPASPS Put American 100 5 BATO 2024-02-16
O:DYAI240216P00002500 OPASPS Put American 100 2.5 BATO 2024-02-16
O:DYAI240216C00007500 OCASPS Call American 100 7.5 BATO 2024-02-16
O:DYAI240216C00005000 OCASPS Call American 100 5 BATO 2024-02-16
O:DYAI240216C00002500 OCASPS Call American 100 2.5 BATO 2024-02-16
O:DYAI240119P00010000 OPASPS Put American 100 10 BATO 2024-01-19
O:DYAI240119P00007500 OPASPS Put American 100 7.5 BATO 2024-01-19
O:DYAI240119P00005000 OPASPS Put American 100 5 BATO 2024-01-19
O:DYAI240119P00002500 OPASPS Put American 100 2.5 BATO 2024-01-19
O:DYAI240119C00010000 OCASPS Call American 100 10 BATO 2024-01-19
O:DYAI240119C00007500 OCASPS Call American 100 7.5 BATO 2024-01-19
O:DYAI240119C00005000 OCASPS Call American 100 5 BATO 2024-01-19
O:DYAI240119C00002500 OCASPS Call American 100 2.5 BATO 2024-01-19
O:DYAI231215P00007500 OPASPS Put American 100 7.5 BATO 2023-12-15
O:DYAI231215P00005000 OPASPS Put American 100 5 BATO 2023-12-15
O:DYAI231215P00002500 OPASPS Put American 100 2.5 BATO 2023-12-15
O:DYAI231215C00007500 OCASPS Call American 100 7.5 BATO 2023-12-15
O:DYAI231215C00005000 OCASPS Call American 100 5 BATO 2023-12-15
O:DYAI231215C00002500 OCASPS Call American 100 2.5 BATO 2023-12-15
O:DYAI231117P00007500 OPASPS Put American 100 7.5 BATO 2023-11-17
O:DYAI231117P00005000 OPASPS Put American 100 5 BATO 2023-11-17
O:DYAI231117P00002500 OPASPS Put American 100 2.5 BATO 2023-11-17
O:DYAI231117C00007500 OCASPS Call American 100 7.5 BATO 2023-11-17
O:DYAI231117C00005000 OCASPS Call American 100 5 BATO 2023-11-17
O:DYAI231117C00002500 OCASPS Call American 100 2.5 BATO 2023-11-17
O:DYAI231020P00007500 OPASPS Put American 100 7.5 BATO 2023-10-20
O:DYAI231020P00005000 OPASPS Put American 100 5 BATO 2023-10-20
O:DYAI231020P00002500 OPASPS Put American 100 2.5 BATO 2023-10-20
O:DYAI231020C00007500 OCASPS Call American 100 7.5 BATO 2023-10-20
O:DYAI231020C00005000 OCASPS Call American 100 5 BATO 2023-10-20
O:DYAI231020C00002500 OCASPS Call American 100 2.5 BATO 2023-10-20
O:DYAI230915P00007500 OPASPS Put American 100 7.5 BATO 2023-09-15
O:DYAI230915P00005000 OPASPS Put American 100 5 BATO 2023-09-15
O:DYAI230915P00002500 OPASPS Put American 100 2.5 BATO 2023-09-15
O:DYAI230915C00007500 OCASPS Call American 100 7.5 BATO 2023-09-15
O:DYAI230915C00005000 OCASPS Call American 100 5 BATO 2023-09-15
O:DYAI230915C00002500 OCASPS Call American 100 2.5 BATO 2023-09-15
O:DYAI230818P00007500 OPASPS Put American 100 7.5 BATO 2023-08-18
O:DYAI230818P00005000 OPASPS Put American 100 5 BATO 2023-08-18
O:DYAI230818P00002500 OPASPS Put American 100 2.5 BATO 2023-08-18
O:DYAI230818C00007500 OCASPS Call American 100 7.5 BATO 2023-08-18
O:DYAI230818C00005000 OCASPS Call American 100 5 BATO 2023-08-18
O:DYAI230818C00002500 OCASPS Call American 100 2.5 BATO 2023-08-18
News Stream
Calendar Calendar of Events
Dyadic to Attend Industry and Investor Events in May
JUPITER, Fla., May 08, 2024 (GLOBE NEWSWIRE) -- Dyadic International, Inc. (“Dyadic”, or the “Company”) (NASDAQ: DYAI), a global biotechnology company focused on building innovative microbial platforms to address the growing demand for global protein bioproduction and to develop and manufacture prophylactic, therapeutic, and nutritional biopharmaceutical products for human and animal health and wellness, today announced that its management will be attending the following industry and investor events during the month of May 2024.
GlobeNewswire Inc. • 1w ago
Calendar Calendar of Events
Dyadic to Report First Quarter 2024 Financial Results on Tuesday, May 14, 2024
JUPITER, Fla., April 30, 2024 (GLOBE NEWSWIRE) -- Dyadic International, Inc. (“Dyadic”, “we”, “us”, “our”, or the “Company”) (NASDAQ: DYAI), a biotechnology company focused on the efficient large-scale manufacture of proteins for use in human and animal vaccines and therapeutics, as well as in non-pharmaceutical applications including food, nutrition, and wellness, today announced that it will report its financial results for the first quarter 2024 and host a corporate update conference call on Tuesday, May 14, 2024.
GlobeNewswire Inc. • 2w ago
Stocks Earnings Releases and Operating Results
Dyadic Reports 2023 Full Year Results and Recent Company Progress
JUPITER, Fla., March 28, 2024 (GLOBE NEWSWIRE) -- Dyadic International, Inc. (“Dyadic”, “we”, “us”, “our”, or the “Company”) (NASDAQ: DYAI), a biotechnology company focused on the efficient large-scale manufacture of proteins for use in human and animal vaccines and therapeutics and for use in non-pharmaceutical applications including food, nutrition, and wellness, today announced its financial results for the year end 2023 and highlighted recent Company progress.
GlobeNewswire Inc. • 1mo ago
Management Directors and Officers
Dyadic Announces Change in Board and Management Leadership Roles
JUPITER, Fla., March 28, 2024 (GLOBE NEWSWIRE) -- Dyadic International, Inc. (“Dyadic”, “we”, “us”, “our”, or the “Company”) (NASDAQ: DYAI), a biotechnology company focused on the efficient large-scale manufacture of proteins for use in human and animal vaccines and therapeutics and for use in non-pharmaceutical applications including food, nutrition, and wellness, today announced that Michael Tarnok is stepping down as Chairman of Dyadic’s board of directors (the “Board”) and that current member of the Board Patrick Lucy has been appointed to succeed him, in each case, effective immediately. Mr. Tarnok will continue to serve as a director through the end of his current term, which will end at the Company’s annual meeting in June 2025, at which time he expects to retire. In addition, Dr. Barry Buckland announced that he is retiring and therefore will not stand for re-election at the Company’s annual meeting in June 2024. The Board has decided not to fill the vacancy due to Dr. Buckland’s retirement which will result in a reduction of the size of the Board from seven to six members. Finally, Joseph Hazelton has been appointed Chief Operating Officer, effective immediately, and will oversee the day-to-day operations of the Company.
GlobeNewswire Inc. • 1mo ago
stocks Product / Services Announcement
Dyadic Announces Publication of C1 Monoclonal Antibody in Nonhuman Primate Study in Nature Communications
JUPITER, Fla., March 26, 2024 (GLOBE NEWSWIRE) -- Dyadic International, Inc. (“Dyadic” or the “Company”) (NASDAQ: DYAI), a global biotechnology company focused on building innovative microbial protein production platforms today announced the online publication of the manuscript "Filamentous fungus-produced human monoclonal antibody provides protection against SARS-CoV-2 in hamster and nonhuman primate models" in Nature Communications (“Springer-Nature"), an international journal publishing peer-reviewed research in all fields of science and technology.
GlobeNewswire Inc. • 1mo ago
News Product / Services Announcement
Dyadic Announces Publication of C1 Monoclonal Antibody in Nonhuman Primate Study in Nature Communications
JUPITER, Fla., March 26, 2024 (GLOBE NEWSWIRE) -- Dyadic International, Inc. (“Dyadic” or the “Company”) (NASDAQ: DYAI), a global biotechnology company focused on building innovative microbial protein production platforms today announced the online publication of the manuscript "Filamentous fungus-produced human monoclonal antibody provides protection against SARS-CoV-2 in hamster and nonhuman primate models" in Nature Communications (“Springer-Nature"), an international journal publishing peer-reviewed research in all fields of science and technology.
GlobeNewswire Inc. • 1mo ago
Calendar Calendar of Events
Dyadic to Attend Future Food Tech Event March 21 – 22, 2024 in San Francisco, California
JUPITER, Fla., March 21, 2024 (GLOBE NEWSWIRE) -- Dyadic International, Inc. (“Dyadic”, or the “Company”) (NASDAQ: DYAI), a global biotechnology company focused on building innovative microbial platforms to address the growing demand for global protein bioproduction and unmet clinical needs for effective, affordable and accessible biopharmaceutical products for human and animal health, and alternative proteins for food, nutrition and wellness, today announced that Joseph Hazelton, Chief Business Officer and Doug Pace, Executive Vice President of Business Development will be attending the Future Food-Tech “Innovation & Investment from Farm to Fork” event March 21 – 22, 2024 at the San Francisco Marriott Marquis in California.
GlobeNewswire Inc. • 1mo ago
Calendar Calendar of Events
Dyadic to Report Full Year 2023 Financial Results and Host Conference call on Thursday, March 28, 2024
JUPITER, Fla., March 14, 2024 (GLOBE NEWSWIRE) -- Dyadic International, Inc. (“Dyadic”, “we”, “us”, “our”, or the “Company”) (NASDAQ: DYAI), a global biotechnology company focused building innovative microbial protein production platforms to address the growing demand for global protein bioproduction utilizing its advanced microbial platforms to develop and manufacture prophylactic, therapeutic, and nutritional biopharmaceutical products for human and animal health and wellness, today announced that it will report its financial results for the year ended 2023 and host a corporate update conference call on Thursday, March 28, 2024.
GlobeNewswire Inc. • 2mo ago
Stocks Financing Agreements
CORRECTION – Dyadic Announces Closing of Private Placement of $6.0 Million Convertible Notes to Accelerate Near-Term Revenue Growth and Commercialization
In a release issued under the same headline on Monday, March 11th by Dyadic International, Inc. (NASDAQ: DYAI), please note that the city in the dateline should be JUPITER, Fla. not JUNIPER, Fla. The corrected release follows:
GlobeNewswire Inc. • 2mo ago
Stocks Financing Agreements
Dyadic Announces Closing of Private Placement of $6.0 Million Convertible Notes to Accelerate Near-Term Revenue Growth and Commercialization
JUNIPER, Fla., March 11, 2024 (GLOBE NEWSWIRE) -- Dyadic International, Inc. ("Dyadic" or the "Company") (NASDAQ: DYAI), a global biotechnology company focused on building innovative microbial protein production platforms to address the growing demand for global protein bioproduction utilizing its advanced microbial platforms to develop and manufacture prophylactic, therapeutic, and nutritional biopharmaceutical products for human and animal health and wellness, announced today that it entered into a securities purchase agreement on March 8, 2024, pursuant to which, the Company has sold and issued an aggregate principal amount of $6.0 million of its 8.0% Senior Secured Convertible Promissory Notes due March 8, 2027 (the “Convertible Notes”) in a private placement in reliance on the exemption from registration provided by Section 4(a)(2) of the Securities Act of 1933, as amended (the “Securities Act”). The purchasers of the Convertible Notes include immediate family members and family trusts related to Mark Emalfarb, our President and Chief Executive Officer and a member of our Board of Directors, including The Francisco Trust, an existing holder of more than 5% of the Company’s outstanding common stock, (collectively, the “Purchasers”).
GlobeNewswire Inc. • 2mo ago
See All
Related
Latest

Contactez-nous dès aujourd'hui pour découvrir comment notre solution peut vous aider à tirer parti de la puissance des données.

CONTACTER UN EXPERT